首页> 外文OA文献 >PGI2 IS THERE ANY DIFFERENCE BETWEEN THE EFFECTS OF THERAPY WITH PEGINTERFERON-ALPHA-2A VERSUS STANDARD-DOSE PEGINTERFERON-ALPHA-2B? A META-ANALYSIS COMPARING BOTH TREATMENTS PLUS RIBAVIRIN IN GENOTYPE 1/4 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION PATIENTS

【2h】

PGI2 IS THERE ANY DIFFERENCE BETWEEN THE EFFECTS OF THERAPY WITH PEGINTERFERON-ALPHA-2A VERSUS STANDARD-DOSE PEGINTERFERON-ALPHA-2B? A META-ANALYSIS COMPARING BOTH TREATMENTS PLUS RIBAVIRIN IN GENOTYPE 1/4 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION PATIENTS

机译：PGI2与PEG-IFN-ALPHA-2A对比标准剂量的PEG-IFN-ALPHA-2B的治疗效果有何不同？两种治疗加利巴韦林的基因分析比较，在基因型1/4慢性丙型肝炎病毒（HCV）感染患者中的应用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Barros FMR; Cheinquer H; Borges LG; Santos E;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Early Changes in Hepatitis C Virus (HCV) Levels in Response to Peginterferon and Ribavirin Treatment in Patients with Chronic HCV Genotype 1 Infection. [J] . Hoofnagle JH, Brown-Jr RS, Belle SH The Journal of Infectious Diseases . 2009,第8期

机译：慢性HCV基因型1感染患者对Peginterferon和Ribavirin治疗的反应中丙型肝炎病毒（HCV）水平的早期变化。
2. Early Changes in Hepatitis C Virus (HCV) Levels in Response to Peginterferon and Ribavirin Treatment in Patients with Chronic HCV Genotype 1 Infection [J] . Jay H. Hoofnagle1 Abdus S. Wahed3 Robert S. Brown Jr.5 Charles D. Howell2 and Steven H.. Bellw34for the Virahep-C Study Groupa Journal of Infectious Diseases . 2009,第8期

机译：丙型干扰素和利巴韦林治疗对慢性HCV基因1型感染患者的早期丙型肝炎病毒（HCV）水平变化
3. OL-006 Impact of mutation in HCV ISDR on the efficacy of the combined pegylated interferon/ribavirin therapy in Chinese patients with chronic hepatitis C virus genotype 1b infection [J] . J.T.Li, J.F.Wei, Y.P.Zhou, International journal of infectious diseases : . 2011,第Supplementa1期

机译：OL-006 HCV ISDR突变对聚乙二醇干扰素/利巴韦林联合治疗对中国慢性丙型肝炎病毒基因1b型患者疗效的影响
4. Influence of hepatitis C virus genotypes and F protein on outcome of HCV infection among injection drug users [C] . Yun Zhang, Jingjing Yang, Haopeng Wang, International symposium on pharmacogenomics and the regulation of drug metabolism enzymes and genes. . 2010

机译：丙型肝炎病毒基因型和F蛋白对注射吸毒者HCV感染结局的影响
5. Population pharmacokinetics and efficacy of ribavirin in patients with chronic hepatitis C genotype 1 infection. [D] . Jin, Runyan. 2010

机译：利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
6. Differences in Hepatitis C Virus (HCV)-Specific CD8 T-Cell Phenotype during Pegylated Alpha Interferon and Ribavirin Treatment Are Related to Response to Antiviral Therapy in Patients Chronically Infected with HCV [O] . Joana Caetano, António Martinho, Artur Paiva, 2008

机译：聚乙二醇化α干扰素和利巴韦林治疗期间丙型肝炎病毒（HCV）特异性CD8 T细胞表型的差异与慢性感染HCV的患者对抗病毒治疗的反应有关
7. PGI24 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Retreatment of Patients with Chronic Hepatitis C Virus Genotype I Infection [O] . Fonseca M., Tannus G., Parisi E. 2012

机译：Boceprevir联合Peginterferon Alpha和Ribavirin与Peginterferon Alfa加上Ribavirin联合治疗慢性丙型肝炎病毒I型基因型感染的成本效益

PGI2 IS THERE ANY DIFFERENCE BETWEEN THE EFFECTS OF THERAPY WITH PEGINTERFERON-ALPHA-2A VERSUS STANDARD-DOSE PEGINTERFERON-ALPHA-2B? A META-ANALYSIS COMPARING BOTH TREATMENTS PLUS RIBAVIRIN IN GENOTYPE 1/4 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION PATIENTS

著录项

引文网络

相似文献

相关主题

期刊订阅